HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahindra Makhija Selected Research

1- (2- fluoro- 4- (1H- pyrazol- 1- yl)phenyl)- 5- methoxy- 3- (1- phenyl- 1H- pyrazol- 5- yl)pyridazin- 4(1H)- one

4/2021Correction to: The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome.
1/2021The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahindra Makhija Research Topics

Disease

2Fragile X Syndrome (Martin Bell Syndrome)
04/2021 - 01/2021
1Meningioma (Meningiomas)
06/2020

Drug/Important Bio-Agent (IBA)

21- (2- fluoro- 4- (1H- pyrazol- 1- yl)phenyl)- 5- methoxy- 3- (1- phenyl- 1H- pyrazol- 5- yl)pyridazin- 4(1H)- oneIBA
04/2021 - 01/2021
1Proteins (Proteins, Gene)FDA Link
06/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2020
1Neurofibromin 2 (Merlin)IBA
06/2020
1Cullin Proteins (Cullins)IBA
06/2020
1AZD 6244IBA
06/2020